Polydatin Alleviated Ischemia–Reperfusion Induced Kidney Injury by Inhibiting SETD2‐Mediated Ferroptosis
Phytotherapy Research · 2025
DOI: 10.1002/ptr.70088 ↗At a glance
Journal article in Phytotherapy Research, 2025. Written by Mu He and 5 co-authors. Institution: Department of Urology, Renmin Hospital of Wuhan University, Wuhan, China. Major MEDLINE topics: Ferroptosis, Stilbenes, Glucosides, Acute Kidney Injury. Cited 2 times so far (Crossref); 35 references. Funded by: National Natural Science Foundation of China.
Abstract (original language)
Ferroptosis, an iron‐ and reactive oxygen species (ROS)‐dependent cell death process, plays a key role in acute kidney injury (AKI). Inhibiting ferroptosis has been shown to mitigate AKI severity, highlighting its potential as a therapeutic target. Lysine methyltransferase SETD2 regulates ferroptosis‐related proteins and may serve as a novel target for ferroptosis inhibitors. Polydatin, a resveratrol glucoside derived from Polygonum cuspidatum , has demonstrated protective effects in septic‐induced AKI, but its role in ischemia–reperfusion‐induced AKI remains unclear. This study investigates whether Polydatin protects against ischemia–reperfusion‐induced AKI in mice and explores the underlying mechanisms. A mouse AKI model was established by clamping renal pedicles for 30 min, followed by Polydatin (40, 80 mg/kg) administration 1 h before injury. Renal function was assessed via serum creatinine (SCr) and blood urea nitrogen (BUN) levels, alongside histopathological analyses. RNA sequencing identified potential mechanisms, and molecular docking examined Polydatin's interaction with SETD2. ChIP‐qPCR was used to assess SETD2‐mediated regulation of ACSL4 via H3K36me3 modification. SETD2 knockout mice were utilized to validate Polydatin's protective mechanism. Polydatin significantly improved renal function, reducing SCr, BUN, and injury biomarkers (NGAL, KIM‐1). In vitro, it alleviated hypoxia/reoxygenation injury in HK‐2 cells. Mechanistically, Polydatin inhibited ferroptosis by targeting SETD2, as confirmed by RNA sequencing and molecular docking. SETD2 overexpression negated Polydatin's benefits, while knockout enhanced protection. Polydatin protects against ischemia–reperfusion‐induced AKI by inhibiting ferroptosis through SETD2 modulation, highlighting its potential for AKI treatment.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Urology, Renmin Hospital of Wuhan University, Wuhan, China.
- Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, China.
- Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China.
Funding
- National Natural Science Foundation of China
Cite
APA
He, M., Tang, S., Wang, L., Hu, X., Yao, X., & Wu, H. (2025). Polydatin Alleviated Ischemia–Reperfusion Induced Kidney Injury by Inhibiting SETD2‐Mediated Ferroptosis. Phytotherapy Research. https://doi.org/10.1002/ptr.70088
Vancouver
He M, Tang S, Wang L, Hu X, Yao X, Wu H. Polydatin Alleviated Ischemia–Reperfusion Induced Kidney Injury by Inhibiting SETD2‐Mediated Ferroptosis. Phytotherapy Research. 2025. doi:10.1002/ptr.70088
BibTeX
@article{He2025,
author = {He, Mu and Tang, Shaoqun and Wang, Liyan and Hu, Xiao and Yao, Xiaobing and Wu, Huailiang},
title = {Polydatin Alleviated Ischemia–Reperfusion Induced Kidney Injury by Inhibiting SETD2‐Mediated Ferroptosis},
journal = {Phytotherapy Research},
year = {2025},
doi = {10.1002/ptr.70088}
}
EUVIMED